Assignee
CURIS INC
US·107 granted patents·41 pending applications·2,268 citations·filing 1994–2025
Top patents by PatentIndex Score
148 records- 0198US6613798B1Small organic molecule regulators of cell proliferationCURIS INC·Filed 2000·Granted Sep 2, 2003·213 cites·59 claims
- 0297US7115653B2Small organic molecule regulators of cell proliferationCURIS INC·Filed 2002·Granted Oct 3, 2006·130 cites·29 claims
- 0397US6552016B1Mediators of hedgehog signaling pathways, compositions and uses related theretoCURIS INC·Filed 2000·Granted Apr 22, 2003·92 cites·43 claims
- 0496US6683108B1Agonists of hedgehog signaling pathways and uses related theretoCURIS INC·Filed 2000·Granted Jan 27, 2004·61 cites·75 claims
- 0596US6545005B1Mediators of hedgehog signaling pathways, compositions and uses related theretoCURIS INC·Filed 2000·Granted Apr 8, 2003·188 cites·35 claims
- 0695US11040948B2Crystal forms of immunomodulatorsCURIS INC·Filed 2018·Granted Jun 22, 2021·12 cites·25 claims
- 0795US8906909B2Phosphoinositide 3-kinase inhibitors with a zinc binding moietyCURIS INC·Filed 2013·Granted Dec 9, 2014·17 cites·20 claims
- 0895US7547781B2Quinazoline based EGFR inhibitors containing a zinc binding moietyCURIS INC·Filed 2007·Granted Jun 16, 2009·15 cites·9 claims
- 0995US6683192B2Small organic molecule regulators of cell proliferationCURIS INC·Filed 2001·Granted Jan 27, 2004·113 cites·30 claims
- 1093US11643401B2Crystal forms of immunomodulatorsCURIS INC·Filed 2021·Granted May 9, 2023·4 cites·12 claims
- 1193US10758518B2Compounds and compositions for treating hematological disordersCURIS INC·Filed 2018·Granted Sep 1, 2020·8 cites·7 claims
- 1293US10676482B2Phosphoinositide 3-kinase inhibitors with a zinc binding moietyCURIS INC·Filed 2019·Granted Jun 9, 2020·3 cites·4 claims
- 1393US7300929B2Mediators of hedgehog signaling pathways, compositions and uses related theretoCURIS INC·Filed 2003·Granted Nov 27, 2007·30 cites·40 claims
- 1492US11939306B2Crystal forms of immunomodulatorsCURIS INC·Filed 2023·Granted Mar 26, 2024·2 cites·12 claims
- 1592US8367663B2Phosphoinositide 3-kinase inhibitors with a zinc binding moietyCURIS INC·Filed 2010·Granted Feb 5, 2013·17 cites·25 claims
- 1692US6326201B1Pancreatic progenitor cells, methods and uses related theretoCURIS INC·Filed 2000·Granted Dec 4, 2001·186 cites·39 claims
- 1792US6291516B1Regulators of the hedgehog pathway, compositions and uses related theretoCURIS INC·Filed 1999·Granted Sep 18, 2001·105 cites·16 claims
- 1891US10336770B2Phosphoinositide 3-kinase inhibitors with a zinc binding moietyCURIS INC·Filed 2017·Granted Jul 2, 2019·7 cites·13 claims
- 1991US8357368B2Methods of treating pancreatic or liver cancer using hedgehog antagonistsCURIS INC·Filed 2010·Granted Jan 22, 2013·24 cites·24 claims
- 2091US6686388B2Regulators of the hedgehog pathway, compositions and uses related theretoCURIS INC·Filed 2001·Granted Feb 3, 2004·48 cites·14 claims
- 2191US2025230169A1Phosphoinositide 3-Kinase Inhibitors with a Zinc Binding MoietyCURIS INC·Filed 2024·Application pending·0 cites
- 2290US9725461B2Phosphoinositide 3-kinase inhibitors with a zinc binding moietyCURIS INC·Filed 2014·Granted Aug 8, 2017·11 cites·18 claims
- 2390US6861404B1Therapies for chronic renal failureCURIS INC·Filed 1997·Granted Mar 1, 2005·82 cites·32 claims
- 2489US7888364B2Pyridyl inhibitors of hedgehog signallingCURIS INC·Filed 2005·Granted Feb 15, 2011·10 cites·55 claims
- 2589US7396809B1Methods and reagents for treating glucose metabolic disordersCURIS INC·Filed 2000·Granted Jul 8, 2008·45 cites·65 claims
- 2688US9657032B2Phosphoinositide 3-kinase inhibitor with a zinc binding moietyCURIS INC·Filed 2015·Granted May 23, 2017·5 cites·21 claims
- 2788US9249156B2Phosphoinositide 3-kinase inhibitor with a zinc binding moietyCURIS INC·Filed 2014·Granted Feb 2, 2016·6 cites·9 claims
- 2888US7977347B2Quinazoline based EGFR inhibitorsCURIS INC·Filed 2007·Granted Jul 12, 2011·11 cites·10 claims
- 2988US7807641B2Methods and reagents for treating glucose metabolic disordersCURIS INC·Filed 2007·Granted Oct 5, 2010·12 cites·34 claims
- 3088US7498304B2Angiogenesis-modulating compositions and usesCURIS INC·Filed 2003·Granted Mar 3, 2009·30 cites·69 claims
- 3188US7445778B2Hedgehog and patched antagonists for inhibiting cell and tissue growth and differentiation and uses thereforCURIS INC·Filed 2001·Granted Nov 4, 2008·16 cites·52 claims
- 3288US6639051B2Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related theretoCURIS INC·Filed 1998·Granted Oct 28, 2003·51 cites·28 claims
- 3388US6498142B1Morphogen treatment for chronic renal failureCURIS INC·Filed 1996·Granted Dec 24, 2002·56 cites·24 claims
- 3487US6616926B1Methods of modulating lipid metabolism and storageCURIS INC·Filed 2000·Granted Sep 9, 2003·21 cites·8 claims
- 3586US6506729B1Methods and compositions for the treatment and prevention of Parkinson's diseaseCURIS INC·Filed 1997·Granted Jan 14, 2003·32 cites·6 claims
- 3686US6495513B1Morphogen-enhanced survival and repair of neural cellsCURIS INC·Filed 1995·Granted Dec 17, 2002·31 cites·2 claims
- 3786US2023192687A1Fused amino pyridine as hsp90 inhibitorsCURIS INC·Filed 2022·Application pending·0 cites
- 3885US6407060B1Method for enhancing functional recovery following central nervous system ischemia or traumaCURIS INC·Filed 1997·Granted Jun 18, 2002·52 cites·30 claims
- 3985US2023227467A1Phosphoinositide 3-kinase inhibitors with a zinc binding moietyCURIS INC·Filed 2023·Application pending·0 cites
- 4084US7816369B2Mediators of hedgehog signaling pathways, compositions and uses related theretoCURIS INC·Filed 2005·Granted Oct 19, 2010·7 cites·13 claims
- 4184US7708998B2Methods of inhibiting unwanted cell proliferation using hedgehog antagonistsCURIS INC·Filed 2003·Granted May 4, 2010·11 cites·63 claims
- 4284US6207804B1Genetically engineered antibody analogues and fusion proteins thereofCURIS INC·Filed 1995·Granted Mar 27, 2001·41 cites·6 claims
- 4383US12178821B2Combination therapies for the treatment of cancerCURIS INC·Filed 2022·Granted Dec 31, 2024·2 cites·30 claims
- 4483US11597732B2Phosphoinositide 3-kinase inhibitors with a zinc binding moietyCURIS INC·Filed 2022·Granted Mar 7, 2023·0 cites·6 claims
- 4583US8846912B2Tartrate salts of quinazoline based EGFR inhibitors containing a zinc binding moietyCURIS INC·Filed 2013·Granted Sep 30, 2014·2 cites·17 claims
- 4683US7846938B2Tartrate salts of quinazoline based EGFR inhibitors containing a zinc binding moietyCURIS INC·Filed 2008·Granted Dec 7, 2010·4 cites·25 claims
- 4783US7056882B2Treatment to prevent loss of and/or increase bone mass in metabolic bone diseasesCURIS INC·Filed 2001·Granted Jun 6, 2006·9 cites·40 claims
- 4882US12252475B2Crystal forms of immunomodulatorsCURIS INC·Filed 2024·Granted Mar 18, 2025·0 cites·8 claims
- 4982US9169244B2Tyrosine kinase inhibitors containing a zinc binding moietyCURIS INC·Filed 2013·Granted Oct 27, 2015·4 cites·10 claims
- 5082US7888361B2Tyrosine kinase inhibitors containing a zinc binding moietyCURIS INC·Filed 2007·Granted Feb 15, 2011·4 cites·9 claims
Showing the top 50 of 148 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →